Lv4
495 积分 2021-08-25 加入
陪伴是最长情的告白
T-Cell malignancies following CAR T-Cell therapy: insights from the FDA adverse event reporting system (FAERS)
1天前
已完结
T-Cell malignancies following CAR T-Cell therapy: insights from the FDA adverse event reporting system (FAERS)
1天前
已完结
Neurotoxicity associated with chimeric antigen receptor T-cell therapy: a real-world study leveraging the FDA Adverse Event Reporting System
1天前
已完结
Neurotoxicity associated with chimeric antigen receptor T-cell therapy: a real-world study leveraging the FDA Adverse Event Reporting System
1天前
已完结
Gastrointestinal infections and gastrointestinal haemorrhage are underestimated but serious adverse events in chimeric antigen receptor T-cell recipients: A real-world study
1天前
已完结
Ocular Toxicities in Chimeric Antigen Receptor T-Cell Therapy: A Real-World Study Leveraging FAERS Database
1天前
已完结
Chimeric antigen receptor T-cell immunotherapies adverse events reported to FAERS database: focus on cytopenias
1天前
已完结
Chimeric antigen receptor T-cell immunotherapies adverse events reported to FAERS database: focus on cytopenias
1天前
已完结
Updated Insights on Cardiac Risks of CD19-Directed Chimeric Antigen Receptor T-cell Therapy: A Pharmacovigilance Study
1天前
求助中
Updated insights on cardiac risks of CD19-directed chimeric antigen receptor T-cell therapy: a pharmacovigilance study
1天前
已完结
皖公网安备34019202002308
